ArticleExperimental and therapeutic medicine2021

Tofacitinib protects intestinal epithelial cells against oxygen-glucose deprivation/reoxygenation injury by inhibiting the JAK/STAT3 signaling pathway.

Jing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.